![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Sarcoidosis: can tofacitinib slay the dragon?
Lack of understanding of the immunology of sarcoidosis has limited therapeutic progress. However, evidence from a small open-label trial suggests that treatment with the Janus kinase inhibitor tofacitinib can ...
-
Article
Open AccessComparison of Pharmacokinetics and Pharmacodynamics of Inhaled Technosphere Insulin and Subcutaneous Insulin Lispro in the Treatment of Type 1 Diabetes Mellitus
This study was performed to satisfy a US Food and Drug Administration post-marketing requirement to compare the dose responses for Technosphere® Insulin (TI; MannKind Corporation, Westlake Village, CA, USA) and s...
-
Chapter
Health Effects of Nanoparticles (Inhalation) from Medical Point of View/Type of Diseases
Our understanding of the functioning of the human body at the molecular and nanometer scale has improved tremendously, our diagnostic and therapeutic options for the effective treatment of severe and chronic d...
-
Article
The challenge of translational research—a perspective from the NINDS
-
Chapter
Development of Cholinergic and Amino Acid Neurotransmitter Systems in the Chick Retina
The presence of a cholinergic system in many vertebrate retinas is well established from biochemical and physiological experiments (Lindeman, 1947; Hebb, 1957; Graham, 1974; Ross and McDougal, 1976; Masland an...
-
Chapter and Conference Paper
Development of Cholinergic and Amino Acid Neurotransmitter Systems in the Chick Retina
The presence of a cholinergic system in many vertebrate retinas is well established from biochemical and physiological experiments (Lindeman, 1947; Hebb, 1957; Graham, 1974; Ross and McDougal, 1976; Masland an...